Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
U.S. September retail sales MoM at 0.2% (vs. 0.40% expected, 0.60% prior)

U.S. September retail sales MoM at 0.2% (vs. 0.40% expected, 0.60% prior)

Bitget2025/11/25 13:30
U.S. September retail sales MoM at 0.2% (vs. 0.40% expected, 0.60% prior).
1

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

The Emergence of ICP Caffeine AI: A Fresh Driving Force for Blockchain Expansion Powered by AI?

- DFINITY Foundation launched ICP Caffeine AI in November 2025, claiming to reduce AI inference costs by 20–40% through on-chain execution. - Institutional partnerships and a deflationary token model drove a 385% ICP price surge in Q4 2025, but dApp activity fell 22.4%, signaling engagement challenges. - The platform’s hybrid cloud partnerships and chain-of-chains design aim to bridge DeFi and traditional finance, yet regulatory scrutiny and C3.ai’s financial instability pose risks. - Experts remain divide

Bitget-RWA2025/11/25 17:04
The Emergence of ICP Caffeine AI: A Fresh Driving Force for Blockchain Expansion Powered by AI?

Nasdaq Biotech’s $212M RAIN Funding Sparks 130% Jump

- Enlivex Therapeutics invests $212M in RAIN tokens via a Nasdaq-listed biotech's first prediction market-focused strategy, driving a 130% price surge. - The move coincides with former Italian PM Matteo Renzi joining Enlivex's board, sparking speculation about institutional crypto adoption and political influence. - RAIN broke key technical resistance levels, reaching $0.006974 and $1.7B market cap, but analysts warn of potential reversals if $0.00800 resistance fails. - Despite Enlivex's 23% YTD stock dec

Bitget-RWA2025/11/25 16:46
Nasdaq Biotech’s $212M RAIN Funding Sparks 130% Jump